What’s Next? Five Things To Look Out For In December
Two Biosimilar Products Face FDA Action Dates
Amgen and Mylan will face US Food and Drug Administration actions dates on two of their biosimilar candidates in December, while ANDA sponsors have date-certain launches for two generic products.
